Home/Pipeline/Bella-Vue 1.0

Bella-Vue 1.0

Ophthalmic diseases (e.g., AMD, diabetic retinopathy)

Device Commercial/Clinical UseActive

Key Facts

Indication
Ophthalmic diseases (e.g., AMD, diabetic retinopathy)
Phase
Device Commercial/Clinical Use
Status
Active
Company

About Uneedle

Uneedle is a specialized medical device developer creating ultra-sharp, ultra-precise silicon microneedles for targeted drug delivery. Its lead platforms are Bella-Vue for suprachoroidal injections in ophthalmology and Bella-mu for intradermal delivery, particularly for cancer vaccines. The company leverages semiconductor manufacturing processes to produce CE-marked and FDA-approved devices, positioning itself as a co-development and manufacturing partner for pharmaceutical companies. Its technology aims to transform complex injections into reliable, in-office procedures with reduced pain and improved precision.

View full company profile

Therapeutic Areas